← Back to headlines
Vertex Pharmaceuticals Announces Health Canada Acceptance for Suzetrigine
Vertex Pharmaceuticals (VRTX) announced that Health Canada has accepted its New Drug Submission (NDS) for Suzetrigine, moving the potential treatment closer to market approval in Canada.
29 May, 06:05 — 29 May, 06:05
Sources
Showing 1 of 1 sources
Related Stories
BOJ Deputy Governor Urges Timely Interest Rate Hike Amid Inflation Pressures
31m ago
Dolly Parton’s Business Empire Thrives Through Dollywood Theme Parks
32m ago
European Renewable Firms Report Record Earnings and Battery Storage Expansions
36m ago
Asian Markets Show Mixed Gains as Nvidia Outlook Offsets Inflation Concerns
38m ago